NAFDAC warns Nigerians against use of recalled Nivea Roll-on deodorant

NAFDAC warns Nigerians against use of recalled Nivea Roll-on deodorant

The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians to the recall of Nivea Black & White Invisible Roll-on deodorant, 50ml labelled as providing 48-hour protection in African climates, following a warning from the European Union Rapid Alert System for Dangerous non-food products in Brussels.

In a notice released on Thursday, NAFDAC stated that the product’s batch number is 93529610.

“The recalled Nivea product is reported to contain 2-(4-tert-Butylbenzyl) propionaldehyde, a chemical prohibited in cosmetic products due to its potential to cause harm to the reproductive system, impair the health of an unborn child, and cause skin irritation and burns to users,” the agency explained.

NAFDAC added that the product is manufactured in Germany with Bar Code Number 42299882.

It advised importers, distributors, retailers, and consumers to exercise caution and vigilance within the supply chain to prevent the importation, distribution, sale, and use of the affected Nivea Roll-on with the specified batch.

“Members of the public in possession of the affected batch should cease sale or use and submit stock to the nearest NAFDAC office.

“Healthcare professionals and consumers are encouraged to report any adverse events experienced with the use of regulated products to the nearest NAFDAC office, via pharmacovigilance@nafdac.gov.ng, E-reporting platforms available at www.nafdac.gov.ng, or through the Med-safety application available for download on Android and iOS,” it added.

Punch

About author

You might also like

Ghana becomes 1st to get COVAX COVID-19 vaccines in Africa

600,000 Oxford-AstraZeneca doses arrive  Accra Ghana has received a historic first shipment of 600,000 doses of AstraZeneca-Oxford COVID-19 vaccines from the COVAX Facility.    Ghana is the first country to

Africa’s malaria vaccine rollout expands

Nearly 10,000 children vaccinated Nearly 10 000 children in Burkina Faso and Cameroon have now received the RTS,S malaria vaccine since being introduced this year. A wider malaria vaccine rollout

PrEP research: Why pregnant, lactating women shouldn’t be excluded – Expert

The Executive Director of New HIV Vaccine and Microbicide Advocacy Society (NHVMAS), Mrs Florita Durueke, has called for the inclusion of pregnant and lactating women in the HIV clinical trial

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply